Study to Evaluate Efficacy, Safety and Tolerability of JTE-051 in Subjects With Active Rheumatoid Arthritis
Clinical trial NCT02919475 · COMPLETED
Trial details
- NCT number
- NCT02919475
- Sponsor
- Akros Pharma Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-14
- Primary completion
- 2018-06-25
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.